id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-275837-2avxd80i	Ahirwar, Ashok Kumar	COVID -19 outbreak – Diabetes aspect and perspective	2020-05-19		.txt	text/plain	578	49	53	Diabetes increases the risk of pneumonia in COVID-19 infected individual and it is an important risk factor for adverse outcome. ACE inhibitor and Angiotensin II Receptor Blockers (ARBs) are the few of drugs used for the appropriate management of diabetic patients. All these may lead to increased severity of COVID-19 infection in diabetic individuals. [4] Moreover, genetic polymorphism of ACE receptor has been shown to be linked with diabetes and it might also facilitate COVID-19 infections. [4] On contrary to this, some researchers say that use of ACE inhibitor or ARBs prevents the binding of COVID-19 virus to ACE receptor and thus may prevent infection. [5] All these are the lacunae in the existing knowledge of ACE inhibitor or ARBs use in diabetic individuals. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?	./cache/cord-275837-2avxd80i.txt	./txt/cord-275837-2avxd80i.txt